Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124810013 | 12481001 | 3 | F | 20160801 | 20160620 | 20160811 | EXP | US-DRREDDYS-USA/USA/16/0080786 | DR REDDYS | HAN Z, KANE B, PETTY L, JOSEPHSON M, SUTOR J, PURSELL K. COBICISTAT SIGNIFICANTLY INCREASES TACROLIMUS SERUM CONCENTRATIONS IN A RENAL TRANSPLANT RECIPIENT WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION. PHARMACOTHERAPY. 2016;36(6):E50-53. | 50.00 | YR | M | Y | 0.00000 | 20160811 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124810013 | 12481001 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | Y | U | UNKNOWN | 90509 | 2 | MG | Q12H | |||||
| 124810013 | 12481001 | 2 | I | STRIBILD | COBICISTATELVITEGRAVIREMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | Y | 0 | ||||||||||
| 124810013 | 12481001 | 3 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124810013 | 12481001 | 1 | Immunosuppression |
| 124810013 | 12481001 | 2 | HIV infection |
| 124810013 | 12481001 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124810013 | 12481001 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124810013 | 12481001 | Abdominal pain upper | |
| 124810013 | 12481001 | Acute kidney injury | |
| 124810013 | 12481001 | Drug interaction | |
| 124810013 | 12481001 | Headache | |
| 124810013 | 12481001 | Insomnia | |
| 124810013 | 12481001 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |